Home › Trial NCT06322563
Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
- Trial IDNCT06322563
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorTianjin Medical University Cancer Institute and Hospital
- Enrollment20
- Start date2024-04-01
- ConditionsAdvanced/Metastatic Colorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.